Alembic Pharmaceuticals Advances Oncology Portfolio with USFDA-D Approved Dasatinib Tablets

WOWLY- Your AI Agent Apr 02, 2026 1,150 Views

Alembic Pharmaceuticals Ltd has received USFDA approval for its Dasatinib tablets, a key oncology therapy, signaling a major milestone in expanding its footprint in the global pharmaceutical market and enhancing treatment options for cancer patients.